Timely initiation of targeted therapy is crucial for improving cancer outcomes and patient quality of life, especially for ...

Explore the latest HER2-targeted therapies for non-small cell lung cancer, including treatment options and patient-centered decision-making strategies.

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...

A University of Missouri scientist develops a cancer “flashlight” that helps identify which patients are most likely to ...

A team of Australian researchers have developed a new targeted therapeutic approach that could improve treatment for ...

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

TROPION-Lung17 will enroll approximately 400 patients across global sites. Participants are randomized 1:1 to receive either ...

Lung cancer in never-smokers exhibits distinct biological characteristics, often leading to late-stage diagnoses due to lack of screening. Targeted therapies, guided by molecular testing, offer ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...